HORMONE THERAPY IN ADVANCED BREAST-CANCER - COMPARISON BETWEEN HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MAP) AND TAMOXIFEN (TMX)

被引：0
|
作者：
PANNUTI, F [1 ]
MARTONI, A [1 ]
FRUET, F [1 ]
CRICCA, A [1 ]
机构：
[1] MALPIGHI HOSP,BOLOGNA,ITALY
来源：
CANCER TREATMENT REPORTS | 1979年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1219 / 1219
页数：1
相关论文
共 50 条
  • [21] CLINICAL AND PHARMACOLOGICAL STUDY OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PATIENTS WITH ADVANCED BREAST-CANCER
    BECHER, R
    MILLER, AA
    GERHOLD, U
    HOFFKEN, K
    SCHMIDT, CG
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 191 - 191
  • [22] A PHASE-II STUDY OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER
    FALKSON, G
    FALKSON, HC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 11 (01) : 16 - 18
  • [23] HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) IN TREATMENT OF ADVANCED BREAST-CANCER
    BASTERT, G
    MICHEL, RT
    MEDIZINISCHE WELT, 1983, 34 (12): : 378 - 382
  • [24] PRIMARY ENDOCRINE THERAPY FOR ADVANCED BREAST-CANCER - TO START WITH TAMOXIFEN OR WITH MEDROXYPROGESTERONE ACETATE
    CASTIGLIONEGERTSCH, M
    PAMPALLONA, S
    VARINI, M
    CAVALLI, F
    BRUNNER, K
    SENN, HJ
    GOLDHIRSCH, A
    METZGER, U
    ANNALS OF ONCOLOGY, 1993, 4 (09) : 735 - 740
  • [25] ON THE ROLE OF ADDITIVE HORMONE MONOTHERAPY WITH TAMOXIFEN, MEDROXYPROGESTERONE ACETATE AND AMINOGLUTETHIMIDE, IN ADVANCED BREAST-CANCER
    PETRU, E
    SCHMAHL, D
    KLINISCHE WOCHENSCHRIFT, 1987, 65 (20): : 959 - 966
  • [26] MEDROXYPROGESTERONE ACETATE (MPA) VERSUS TAMOXIFEN IN ADVANCED BREAST-CANCER
    MORANDI, P
    FORNASIERO, A
    DANIELE, O
    AVERSA, SML
    GHIOTTO, C
    FOSSER, VP
    FIORENTINO, MV
    TUMORI, 1986, 72 (06) : 719 - 719
  • [27] HIGH-DOSE VERSUS LOW-DOSE MEDROXYPROGESTERONE ACETATE - A RANDOMIZED TRIAL IN ADVANCED BREAST-CANCER
    GALLAGHER, CJ
    CAIRNDUFF, F
    SMITH, IE
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (12): : 1895 - 1900
  • [28] WEEKLY DOXORUBICIN WITH OR WITHOUT HIGH-DOSE A MEDROXYPROGESTERONE ACETATE IN HORMONE-RESISTANT ADVANCED BREAST-CANCER - A RANDOMIZED STUDY
    GUNDERSEN, S
    HANNISDAL, E
    LUNDGREN, S
    WIST, E
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (12) : 1775 - 1778
  • [29] ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE TREATMENT FOR RECURRENT BREAST-CANCER
    IINO, Y
    TAKEO, T
    SUGAMATA, N
    AOYAGI, H
    TAKAI, Y
    TAKEI, H
    ANDO, T
    KOIBUCHI, Y
    YOKOE, T
    OHWADA, S
    HORIGUCHI, J
    MORISHITA, Y
    ANTICANCER RESEARCH, 1995, 15 (03) : 1061 - 1064
  • [30] HORMONAL-THERAPY IN ADVANCED BREAST-CANCER - SEQUENTIAL ADMINISTRATION OF TAMOXIFEN AND MEDROXYPROGESTERONE ACETATE
    POUILLART, P
    PALANGIE, T
    JOUVE, M
    GARCIAGIRALT, E
    MAGDELENAT, H
    MARTIN, PM
    BULLETIN DU CANCER, 1982, 69 (02) : 176 - 177
12345